Wittekind Amends Renovaro Inc. Ownership Filing

Ticker: LNAI · Form: SC 13D/A · Filed: Jun 24, 2024 · CIK: 1527728

Renovaro Inc. SC 13D/A Filing Summary
FieldDetail
CompanyRenovaro Inc. (LNAI)
Form TypeSC 13D/A
Filed DateJun 24, 2024
Risk Levelmedium
Pages5
Reading Time7 min
Key Dollar Amounts$0.0001, $1.58, $1.55, $165
Sentimentneutral

Sentiment: neutral

Topics: ownership-change, sec-filing, amendment

Related Tickers: RENN

TL;DR

Wittekind filed an ownership update for Renovaro Inc. (RENN) - check for changes.

AI Summary

William Anderson Wittekind filed Amendment No. 17 to Schedule 13D on June 24, 2024, for Renovaro Inc. The filing indicates a change in beneficial ownership of the company's common stock. Wittekind's address is listed as 8581 Santa Monica Blvd. #317, West Hollywood, CA 90069.

Why It Matters

This filing updates information regarding significant beneficial ownership, which can signal changes in control or strategic direction for Renovaro Inc.

Risk Assessment

Risk Level: medium — Schedule 13D filings, especially amendments, can indicate significant shifts in major shareholder positions, potentially impacting stock price and company strategy.

Key Players & Entities

  • William Anderson Wittekind (person) — Filing party and beneficial owner
  • Renovaro Inc. (company) — Subject company
  • 29350E 104 (other) — CUSIP Number for Renovaro Inc. common stock

FAQ

What is the specific change in beneficial ownership reported in this amendment?

The filing is an amendment to Schedule 13D and does not explicitly detail the specific change in beneficial ownership within the provided text. It serves as an update to previously filed information.

Who is William Anderson Wittekind in relation to Renovaro Inc.?

William Anderson Wittekind is the filing party and is identified as a beneficial owner of Renovaro Inc.'s common stock.

What is the CUSIP number for Renovaro Inc. common stock?

The CUSIP number for Renovaro Inc. common stock is 29350E 104.

When was this amendment filed with the SEC?

This amendment (Amendment No. 17) was filed with the SEC on June 24, 2024.

What were the former names of Renovaro Inc.?

Renovaro Inc. was formerly known as Renovaro Biosciences Inc. (name change on 20230807 and 20230802) and Enochian Biosciences Inc. (name change on 20230804).

Filing Stats: 1,628 words · 7 min read · ~5 pages · Grade level 8.7 · Accepted 2024-06-24 19:56:04

Key Financial Figures

  • $0.0001 — ame of Issuer) Common Stock, par value $0.0001 (Title of Class of Securities) 29350
  • $1.58 — Rule 144 at a weighted average price of $1.58. The prices for such sales ranged from
  • $1.55 — . The prices for such sales ranged from $1.55 to $165, inclusive, and the undersigned
  • $165 — ces for such sales ranged from $1.55 to $165, inclusive, and the undersigned underta

Filing Documents

Purpose of Transaction

Item 4. Purpose of Transaction The information in Item 6 of this Amendment No. 17 is hereby incorporated by reference into this Item 4.

Interests in Securities

Item 5. Interests in Securities of the Issuer (a)-(b) The information in Items 7-11 and Item 13 of the cover page of this Amendment No. 17, including the accompanying footnotes, is hereby incorporated by reference into this Item 5. (c) On June 14, 2024 Weird Science sold 50,000 shares of Common Stock in brokers’ transactions pursuant to Rule 144 at a weighted average price of $1.58. The prices for such sales ranged from $1.55 to $165, inclusive, and the undersigned undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Commission, upon request, full information regarding the number of shares sold at each separate price within the reported range. (d) Not applicable. (e) Not applicable. 4

. Contracts, Arrangements, Understandings

Item 6 . Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer. First Amended Stockholder Derivative Complaint On May 29, 2024 the District Court for the Central District of California granted the application of Weird Science and Mr. Wittekind to extend the deadline for amending the Derivative Complaint to June 21, 2024. On June 21, 2024 Weird Science and Wittekind filed the First Amended Derivative Complaint with the District Court for the Central District of California. A copy of the First Amended Derivative Complaint is attached to this Amendment No. 17 as Exhibit 25. Oppositions to Motions to Dismiss First Amended Registration Rights Complaint On June 7, 2024 Weird Science and Wittekind (individually and in his capacity as the sole trustee of the Trusts) filed with the Delaware Court of Chancery oppositions to the defendants’ motions to dismiss the First Amended Registration Rights Complaint. Resales of Common Stock To the extent any shares of Common Stock owned by Weird Science, Wittekind or the Trusts are included in a registration statement that is filed by the Issuer and declared effective by the SEC (including, without limitation, the Form S-1 that the Issuer agreed to file to register resales by Lincoln Park Capital Fund LLC pursuant to the Registration Rights Agreement between the Issuer and Lincoln Park dated June 20, 2023), Weird Science, Wittekind and the Trusts (as applicable) intend to resell shares under such registration statement(s) in accordance with the Investor Rights Agreement. In addition, as set forth in the Form 144s filed with the Commission on June 6, 2024 and June 11, 2024, Wittekind intends to sell up to 275,049 shares of Common Stock pursuant to Rule 144 and Wittekind intends to cause Weird Science to sell up to 1,200,000 shares of Common Stock pursuant to Rule 144 (including the 50,000 shares sold by Weird Science on June 14, 2024).

Material

Item 7. Material to be Filed as Exhibits Exhibit 25 First Amended Verified Stockholder Derivative Complaint filed with the United States District Court for the Central District of California–Western Division, on June 21, 2024. 5 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this Amendment No. 17 is true, complete and correct. Date: June 24, 2024 /s/ William Anderson Wittekind WILLIAM ANDERSON WITTEKIND 6

View Full Filing

View this SC 13D/A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.